Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Personalized Gait Retraining to Support Knee Health in Older Adults (BiofeedbackRCT)

15 november 2026 uppdaterad av: Lauri Stenroth, University of Eastern Finland

A Real-time Biofeedback Intervention for Improving Tibiofemoral Cartilage Quality in Older Adults

Participants are randomized into two groups: gait retraining and habitual walking. In the gait retraining group, an intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. Real-time visual biofeedback on a knee joint loading metric is provided during some of the training sessions to facilitate learning. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Changes in knee joint cartilage properties are assessed at 5 months.

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Detaljerad beskrivning

In this randomized controlled intervention study, participants are randomized into two groups: gait retraining and habitual walking. At baseline and five months later, participants' gait mechanics and knee joint cartilage structure and quality are assessed, and blood and urine samples and questionnaire data are collected. In addition, knee joint radiographic status is assessed at baseline. Physical activity is monitored using a thigh-worn accelerometer throughout the study.

The intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. During the first session, participants try different kinematics-based gait modifications to personalize the intervention. The modifications that reduce estimated medial tibiofemoral knee joint loading the most are selected and utilized during the following sessions. The gait retraining aims at establishing a gait pattern for each individual that reduces medial tibiofemoral joint loading while also being such that the person can utilize it in their daily living. To support learning and fine-tuning the gait pattern, real-time feedback on knee joint moments is provided during part of the training sessions. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Eight of the training sessions are conducted within four weeks, while the two remaining sessions (so-called boosters) are conducted during the following four months with the aim of supporting maintenance of the learned gait pattern.

Pre-planned additional follow-ups are planned for 12 and 24 months from baseline. Knee MRI would be conducted at these follow-up points, with implementation depending on funding.

Studietyp

Interventionell

Inskrivning (Beräknad)

70

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

65 år till 74 år (Äldre vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Age above 65 or below 75 years (in full years)
  • Access to a smartphone or tablet with an Android or iOS operating system

Exclusion Criteria:

  • Unable to walk for 30 minutes without stopping and without an assistive device
  • Body mass index <18 or >30 kg/m2
  • Pain during walking
  • Diagnosed with knee osteoarthritis
  • Moderate (KL Grade 3) or severe (KL Grade 4) radiographical tibiofemoral osteoarthritis based on Kellgren-Lawrence (KL) Classification of Osteoarthritis
  • Diagnosed with neurological disease
  • Surgery of the knee joint
  • Surgery or injury to the lower limbs causing pain or affecting mobility
  • Current musculoskeletal injury causing pain or affecting mobility
  • Contraindication for magnetic resonance imaging
  • Contraindication for walking-based exercise training (e.g., cardiovascular symptoms that increase with exercise or recommendation from a medical professional to avoid moderate exercise)
  • Any other condition that, in the opinion of the investigator, makes a potential participant unfit for participation or conditions that put a potential participant at risk by participation

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Grundläggande vetenskap
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Gait retraining

The arm receives personalized gait retraining via treadmill walking and real-time feedback.

Personalized gait retraining using small kinematic alterations guided by real-time feedback of knee joint loading. The training is perfomed on a treadmill.

Övrig: Habitual walking

The arm receives equal amount of treadmill walking without feedback or instruction to alter the gait.

Participants receive equal amount of treadmill walking as the ones receiving gait retraining intervention. This intervention serves as the comparator for the gait retraining intervention.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Medial tibiofemoral T1ρ relaxation time
Tidsram: Baseline and 5 months

T1ρ relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI

Baseline and 5 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Medial tibiofemoral T2 relaxation time
Tidsram: Baseline and 5 months

T2 relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI

Baseline and 5 months
Lateral tibiofemoral T1ρ relaxation time
Tidsram: Baseline and 5 months

T1ρ relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI

Baseline and 5 months
Lateral tibiofemoral T2 relaxation time
Tidsram: Baseline and 5 months

T2 relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI

Baseline and 5 months
Tibiofemoral loading during walking
Tidsram: Baseline and 5 months

Tibiofemoral loading during walking assessed using musculoskeletal simulation

Baseline and 5 months
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Tidsram: Baseline and 5 months

The score range is from 0 to 100. 0 represents extreme problems / worst possible knee symptoms. 100 represents no problems / perfect knee health.

Baseline and 5 months

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
High-sensitivity C-reactive protein (hs-CRP)
Tidsram: Baseline and 5 months

hs-CRP (mg/L) is measured from blood samples using a particle-enhanced immunoturbidimetric assay as a marker of systemic inflammation.

Baseline and 5 months
Glycated hemoglobin (HbA1c)
Tidsram: Baseline and 5 months

HbA1c (mmol/mol) is measured from blood samples using turbidimetric inhibition immunoassay as a marker of long-term blood glucose control.

Baseline and 5 months
Knee cartilage recovery rate after loading assessed from magnetic resonance images
Tidsram: Baseline and 5 months

The knee joint is loaded with 20 minutes of standing and followed by repeated magnetic resonance imaging. Cartilage is segmented from the images, and the temporal recovery of the cartilage thickness in the medial tibiofemoral joint is quantified. The unit is mm/min.

Baseline and 5 months
Proteomic analysis of serum samples
Tidsram: Baseline and 5 months

Liquid chromatography-mass spectrometry is used to run non-targeted peptide analysis of serum proteins. This is a pre-planned exploratory analysis that identifies hundreds of proteins and their concentration in the sample.

Baseline and 5 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Lauri Stenroth, PhD, University of Eastern Finland

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

15 november 2026

Primärt slutförande (Beräknad)

28 februari 2028

Avslutad studie (Beräknad)

31 mars 2028

Studieregistreringsdatum

Först inskickad

4 november 2026

Först inskickad som uppfyllde QC-kriterierna

15 november 2026

Första postat (Faktisk)

20 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

20 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

15 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 125/2025
  • 363854 (Annat bidrag/finansieringsnummer: Research Council of Finland)
  • FIMEA/2025/007528-5 (Annan identifierare: Finnish Medicines Agency)
  • 125/2025 (Annan identifierare: The Regional Medical Research Ethics Committee of Eastern Finland Collaborative Area)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

IPD used in the publications is planned to be shared.

Tidsram för IPD-delning

At the time of publication with no end date.

Kriterier för IPD Sharing Access

Open access to the IPD and supporting information to be used in scientific research. If possible, the data is made available at the time of publishing the results with link to the data repository at the publication.

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL
  • SAV
  • ICF

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera